🇺🇸 FDA
Pipeline program

E004 (epinephrine inhalation aerosol), 90 mcg/actuation

API-E004-CL-A

Phase 2 small_molecule terminated

Quick answer

E004 (epinephrine inhalation aerosol), 90 mcg/actuation for Asthma is a Phase 2 program (small_molecule) at Amphastar Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
Amphastar Pharmaceuticals
Indication
Asthma
Phase
Phase 2
Modality
small_molecule
Status
terminated

Clinical trials